Exact Mass: 451.2699

Cytochalasin Opho

3-benzyl-6,12,15-trihydroxy-4,5,10,12-tetramethyl-1H,2H,3H,6H,6aH,9H,10H,11H,12H,15H,15bH-cycloundeca[e]isoindol-1-one

Cytochalasin Opho is a mycotoxin produced by Phomopsis sp Mycotoxin production by Phomopsis species

LysoPE(16:1(9Z)/0:0)

(2-aminoethoxy)[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropoxy]phosphinic acid

LysoPE(16:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(16:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

LysoPE(0:0/16:1(9Z))

(2-aminoethoxy)[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropoxy]phosphinic acid

LysoPE(0:0/16:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/16:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

Dibekacin

(2R,3R,4S,5S,6R)-4-Amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-YL]oxy-2-hydroxy-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol

Dihydroxylysinonorleucine

6-amino-2-[3-(5-amino-1-carboxy-4-hydroxypentyl)-2-(1-carboxypentyl)triazan-1-yl]-5-hydroxyhexanoic acid

Platelet-activating factor

3,5,9-Trioxa-4-phosphaeicos-19-en-1-aminium, 7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-, inner salt, 4-oxide, (R)-

dibekacin

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A kanamycin that is kanamycin B lacking the 3- and 4-hydroxy groups on the 2,6-diaminosugar ring. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

LysoPE(16:1/0:0)

(2-aminoethoxy)[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropoxy]phosphinic acid

PE(16:1(9Z)/0:0)

1-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

Cytochalasin Opho

3-benzyl-6,12,15-trihydroxy-4,5,10,12-tetramethyl-1H,2H,3H,6H,6aH,9H,10H,11H,12H,15H,15bH-cycloundeca[e]isoindol-1-one

PC O-13:1

1-(10E-undecenyl)-2-acetyl-sn-glycero-3-phosphocholine

LPE 16:1

2-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine

[(3S)-3,4-di(hexanoyloxy)butyl]-[2-(trimethylazaniumyl)ethoxy]phosphinate

1-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine

a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C16:1)

a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C16:1)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] hexadec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-hexadec-11-enoate

6-Amino-2-[2-[(5-amino-1-carboxy-4-hydroxypentyl)amino]-2-(1-carboxypentyl)hydrazinyl]-5-hydroxyhexanoic acid

(11)-Cytochalasa-6(12),13-diene-1,21-dione-7,9-dihydroxy-16,18-dimethyl-lO-phenyl-(7S,13E,16S,18R,19R)

(11)-Cytochalasa-6(12),13-diene-1,21-dione-7,9-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,13E,16S*,18R*,19R*)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-hexadec-9-enoate

[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-hexadec-9-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-hexadec-7-enoate

Terpendole G

1-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

LysoPE(0:0/16:1(9Z))

1-(10E-undecenyl)-2-acetyl-sn-glycero-3-phosphocholine

PE(16:1)

PE(8:1(1)_8:0)

PC P-13:0 or PC O-13:1

LPE 0:0/16:1(9Z)

LPE 16:1(9Z)/0:0

PE O-14:1/2:0

PE O-16:1

PE P-14:0/2:0

PE P-14:0/2:0 or PE O-14:1/2:0

PE P-16:0

PE P-16:0 or PE O-16:1

ST 26:6;O2;Gly

(3r,3as,4r,6r,6as,10r,12s,13s,15ar)-3-benzyl-1,6,13-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

16-benzyl-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.0¹,¹⁵.0³,¹⁰]octadeca-4,17-diene-2,9,12,18-tetrol

(3s,3ar,4s,6ar,15r)-3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindole-1,6,12,15-tetrol

(1r,2r,3s,7r,9r,10s,11r,12s,14s,15r,16s)-16-benzyl-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.0¹,¹⁵.0³,¹⁰]octadeca-4,17-diene-2,9,12,18-tetrol

5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-5-oxo-2h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(1r,2r,3z,5r,7s,9z,11r,12s,14r,15s,16r,17s)-17-benzyl-5,7,14,15-tetramethyl-13-oxa-18-azatetracyclo[9.8.0.0¹,¹⁶.0¹²,¹⁴]nonadeca-3,9,18-triene-2,5,19-triol

3-[(2-hydroxyphenyl)methyl]-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,15h-cycloundeca[d]isoindole-1,6,15-triol

3-benzyl-1,6,13-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3r,3as,4r,6r,6as,10r,12r,15s,15as)-3-[(2-hydroxyphenyl)methyl]-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,15h-cycloundeca[d]isoindole-1,6,15-triol

(3s,3ar,6s,6ar,10s,12r,15r,15ar)-3-benzyl-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindole-1,6,12,15-tetrol

3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one

3-benzyl-1,6,12-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one

10,18-dichloro-n-(1-hydroxy-3-methoxypropan-2-yl)-n-methyloctadec-4-enamide

C23H43Cl2NO3 (451.262)

(4ar,5s,6r,8ar)-5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-5-oxo-2h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(3s,3ar,6s,6ar,10s,12r,15as)-3-benzyl-1,6,12-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one

(1s,2s,5s,7s,9r,10s,11r,14s)-9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carbaldehyde

(1s,2s,5s,7s,9r,10s,11r,14s)-9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carbaldehyde

(3r,6s,9e,14r,15r)-5,8,13-trihydroxy-14-(2-hydroxyethyl)-3-isopropyl-6-methyl-11-methylidene-15-[(2r)-pentan-2-yl]-1-oxa-4,7,12-triazacyclopentadeca-4,7,9,12-tetraen-2-one

C23H37N3O6 (451.2682)

(10r)-10,18-dichloro-n-[(2r)-1-hydroxy-3-methoxypropan-2-yl]-n-methyloctadec-4-enamide

C23H43Cl2NO3 (451.262)

(3s,3ar,4s,6s,6ar,10s,12s,15r,15ar)-3-[(4-hydroxyphenyl)methyl]-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,15h-cycloundeca[d]isoindole-1,6,15-triol

(3s,3ar,4s,6s,6ar,10s,12s,15r,15ar)-3-[(3-hydroxyphenyl)methyl]-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,15h-cycloundeca[d]isoindole-1,6,15-triol

(4ar,5s,6r,8ar)-5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carboxylic acid

(4as,5r,6s,8as)-5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(3s,3ar,4s,6s,6ar,10s,12r,15as)-3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one

(1s,2s,5s,7s,10r,11r,14s)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carboxylic acid

(3s,3ar,4s,6s,6ar,10s,12r,15r,15as)-3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindole-1,6,12,15-tetrol

(3s,3ar,4s,6s,6ar,10s,12r,15r)-3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindole-1,6,12,15-tetrol

(3s,3ar,4s,6s,6ar,10s,12s,15r,15ar)-3-benzyl-10-(hydroxymethyl)-4,12-dimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,15h-cycloundeca[d]isoindole-1,6,15-triol

(4as,5r,6s,8as)-5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-5-oxo-2h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

(3s,3ar,4s,6s,6ar,10s,12r,15ar)-3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindol-15-one

5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-2-oxo-5h-pyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

n-(5-carbamimidamido-1-hydroxypentan-2-yl)-2-{[1,2-dihydroxy-4-(4-hydroxyphenyl)butylidene]amino}-3-methylpentanimidic acid

C22H37N5O5 (451.2795)

(4e)-10,18-dichloro-n-(1-hydroxy-3-methoxypropan-2-yl)-n-methyloctadec-4-enamide

C23H43Cl2NO3 (451.262)

9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carbaldehyde

(1s,2r,5s,7s,9s,10s,11r,14s)-9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carbaldehyde

(1s,2r,5s,7s,9s,10s,11r,14s)-9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraene-10-carbaldehyde